ARCHIVES

Chabner Criticizes FDA Crackdown On Off-Label Info

This article is from The Cancer Letter archive.

Vol. 17 No. 26 | June 28, 1991

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

November 20, 1998

House Panel Provides NCI $1.7 Billion for 1991, Expects Greater Emphasis On Cancer Prevention

July 20, 1990

Heidelberger Wins $100,000 Award

September 17, 1982

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

May 11, 2012

RFP, RFA Available

March 26, 1993